Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection
Clinical trial NCT03575806 · COMPLETED
Trial details
- NCT number
- NCT03575806
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-09
- Primary completion
- 2019-10-31
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.